Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Aspirin + Extended Release Dipyridamole / Telmisartan	5,086
Overall Study	STARTED	Aspirin + Extended Release Dipyridamole / Placebo	5,095
Overall Study	STARTED	Clopidogrel / Telmisartan	5,060
Overall Study	STARTED	Clopidogrel / Placebo	5,091
Overall Study	COMPLETED	Aspirin + Extended Release Dipyridamole / Telmisartan	4,699
Overall Study	COMPLETED	Aspirin + Extended Release Dipyridamole / Placebo	4,689
Overall Study	COMPLETED	Clopidogrel / Telmisartan	4,645
Overall Study	COMPLETED	Clopidogrel / Placebo	4,680
Overall Study	NOT COMPLETED	Aspirin + Extended Release Dipyridamole / Telmisartan	387
Overall Study	NOT COMPLETED	Aspirin + Extended Release Dipyridamole / Placebo	406
Overall Study	NOT COMPLETED	Clopidogrel / Telmisartan	415
Overall Study	NOT COMPLETED	Clopidogrel / Placebo	411

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00153062/flow